Candel Therapeutics (CADL) Research & Development (2020 - 2025)
Candel Therapeutics (CADL) reported Research & Development of $290000.0 for Q4 2025, up 108.41% on a YoY basis from $139148.3 in Q4 2024, and down 96.57% sequentially from $8.5 million in Q3 2025.
Candel Therapeutics (CADL) Research & Development (2020 - 2025) Analysis & Trends
Candel Therapeutics (CADL) has 6 years of Research & Development data on file, last reported at $290000.0 in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 108.41% year-over-year to $290000.0; the trailing twelve-month figure through Dec 2025 stood at $17.0 million (up 272.77% YoY), and the FY2025 full-year result was $937000.0, up 87.78% from the prior year.
- Research & Development slipped to $290000.0 in Q4 2025, from $8.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $8.5 million in Q3 2025 to a low of -$3.4 million in Q4 2024.
- A 5-year average of $4.1 million and a median of $5.0 million in 2022 frame the typical range for Research & Development.
- Across the five-year window, Research & Development sank 147.51% in 2024 and jumped 284.59% in 2025, its largest moves.
- Tracing CADL's Research & Development over 5 years: stood at $3.9 million in 2021, then climbed by 29.01% to $5.0 million in 2022, then jumped by 45.98% to $7.3 million in 2023, then slumped by 147.51% to -$3.4 million in 2024, then soared by 108.41% to $290000.0 in 2025.
- Business Quant data shows CADL's Research & Development at $290000.0 in Q4 2025, $8.5 million in Q3 2025, and $7.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Candel Therapeutics | 542.51 Mn | 542.51 Mn | - | 290,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | 8.46 Mn |
| Jun 30, 2025 | 6.99 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | -3.45 Mn |
| Sep 30, 2024 | 2.20 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 826,000.00 |
| Dec 31, 2023 | 7.26 Mn |
| Sep 30, 2023 | 5.85 Mn |
| Jun 30, 2023 | 5.93 Mn |
| Mar 31, 2023 | 5.47 Mn |
| Dec 31, 2022 | 4.97 Mn |
| Sep 30, 2022 | 5.38 Mn |
| Jun 30, 2022 | 5.02 Mn |
| Mar 31, 2022 | 5.42 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Sep 30, 2021 | 5.27 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Mar 31, 2021 | 2.75 Mn |